EyePoint (EYPT) Stock Price, Quote, News & History | Benzinga

SPY770.84+0.23%QQQ721.79+0.58%BTC/USD83,686.36+0.90%DIA524.75+0.07%GLD379.08+0.38%TLT80.41+0.34%

EyePoint Inc (EYPT) Stock Price, Quote, News & History

EYPTNASDAQ

Trade with Public

Trade with Public

$0.4088

0.00360.89%

Last update: Oct 21, 9:40 AM

$0.4040

-0.0012-0.3%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$0.41

Close

-

Volume / Avg.

2.03M / 6.84M

Day Range

$0.41 - $0.42

52 Wk Range

0.40 - 19.11

Market Cap

$35.24M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

16

Short Interest

25.38%

Days to Cover

5.38

Recent EyePoint Inc News

Amazon.com, Cleveland-Cliffs, Disc Medicine, Silence Therapeutics and EyePoint: Why These 5 Stocks Are on Investors' Radars Today

Major U.S. indices ended mixed on Monday, with the Dow Jones Industrial Average slipping 0.07% to 51,966.03.

Shivdeep Dhaliwal

Crude Oil Moves Higher; US Homebuilder Sentiment Falls In October

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 300 points on Monday.The Dow traded up 0.06% to 52,031.59 while the NASDAQ jumped 1.24% to 26,465.39. The S&P 500 also

Avi Kapoor

EyePoint Slashing Workforce, Halting Clinical Trials to Pivot Focus

EyePoint cuts 53% of staff and halts wet AMD trials after DURAVYU misses its Phase 3 primary endpoint, pivoting its focus entirely to DME.

Vandana Singh

Nasdaq Surges Over 1%; Fifth Third Bancorp Earnings Top Views

U.S. stocks mixed: Nasdaq +1.09%, S&P 500 +0.54%, Dow -0.12%. Tech led gains; utilities lagged. Oil fell, gold rose; Europe lower.

Avi Kapoor

Xenon Pharmaceuticals, Steel Dynamics, Nucor And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. futures rise, but Xenon plunges 27.6% after pausing psychiatry trial enrollment over neuropsychiatric adverse events; other stocks also fall

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-267.30M

Investing Cash Flow (TTM)

114.88M

Financing Cash Flow (TTM)

191.74M

Free Cash Flow (TTM)

-271.28M

Capital Expenditure (TTM)

-3.98M

Net Change in Cash (TTM)

39.32M

Analyst Trends and Forecast

3

Jul

6

3

Aug

0

0

0

0

Sep

2

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.4

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$125.59M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

11.89

PB Ratio (TTM)

0.21

Earnings Yield % (TTM)

-921.83%

Earnings Yield % (FWD)

-824.73%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.93

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$111.00K

Total Cash

$110.46M

Debt to Equity

0.12

Issuance of Debt (TTM)

-$111.00K

Repayment of Debt (TTM)

-$111.00K